持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/02/10 | 3,760 | 3,790 | 3,725 | 3,745 | +15 | +0.4% | 32,600 |
| 2026/02/09 | 3,790 | 3,790 | 3,705 | 3,730 | +80 | +2.2% | 82,200 |
| 2026/02/06 | 3,720 | 3,795 | 3,635 | 3,650 | -95 | -2.5% | 104,500 |
| 2026/02/05 | 3,745 | 3,785 | 3,735 | 3,745 | +35 | +0.9% | 37,000 |
| 2026/02/04 | 3,685 | 3,755 | 3,660 | 3,710 | +40 | +1.1% | 52,200 |
| 2026/02/03 | 3,635 | 3,710 | 3,635 | 3,670 | +65 | +1.8% | 41,000 |
| 2026/02/02 | 3,620 | 3,675 | 3,595 | 3,605 | -15 | -0.4% | 35,100 |
| 2026/01/30 | 3,565 | 3,625 | 3,555 | 3,620 | +75 | +2.1% | 37,400 |
| 2026/01/29 | 3,515 | 3,545 | 3,455 | 3,545 | -5 | -0.1% | 36,800 |
| 2026/01/28 | 3,605 | 3,605 | 3,540 | 3,550 | -75 | -2.1% | 34,500 |
| 2026/01/27 | 3,635 | 3,635 | 3,600 | 3,625 | -50 | -1.4% | 30,400 |
| 2026/01/26 | 3,675 | 3,725 | 3,655 | 3,675 | -65 | -1.7% | 33,000 |
| 2026/01/23 | 3,675 | 3,740 | 3,670 | 3,740 | +70 | +1.9% | 32,000 |
| 2026/01/22 | 3,670 | 3,725 | 3,650 | 3,670 | +5 | +0.1% | 24,700 |
| 2026/01/21 | 3,625 | 3,665 | 3,620 | 3,665 | +15 | +0.4% | 29,500 |
| 2026/01/20 | 3,660 | 3,675 | 3,625 | 3,650 | -30 | -0.8% | 22,200 |
| 2026/01/19 | 3,695 | 3,715 | 3,675 | 3,680 | -10 | -0.3% | 20,800 |
| 2026/01/16 | 3,675 | 3,700 | 3,635 | 3,690 | -35 | -0.9% | 31,200 |
| 2026/01/15 | 3,685 | 3,725 | 3,635 | 3,725 | +60 | +1.6% | 42,000 |
| 2026/01/14 | 3,600 | 3,710 | 3,600 | 3,665 | +35 | +1% | 47,500 |
| 2026/01/13 | 3,660 | 3,675 | 3,605 | 3,630 | +15 | +0.4% | 35,100 |
| 2026/01/09 | 3,670 | 3,690 | 3,605 | 3,615 | -55 | -1.5% | 35,200 |
| 2026/01/08 | 3,625 | 3,700 | 3,625 | 3,670 | +45 | +1.2% | 58,100 |
| 2026/01/07 | 3,535 | 3,675 | 3,535 | 3,625 | +60 | +1.7% | 64,100 |
| 2026/01/06 | 3,540 | 3,565 | 3,510 | 3,565 | +25 | +0.7% | 40,900 |
| 2026/01/05 | 3,545 | 3,585 | 3,505 | 3,540 | +5 | +0.1% | 41,400 |
| 2025/12/30 | 3,600 | 3,610 | 3,515 | 3,535 | +65 | +1.9% | 57,200 |
| 2025/12/29 | 3,450 | 3,470 | 3,435 | 3,470 | +25 | +0.7% | 32,700 |
| 2025/12/26 | 3,460 | 3,460 | 3,420 | 3,445 | +15 | +0.4% | 20,700 |
| 2025/12/25 | 3,405 | 3,435 | 3,405 | 3,430 | -5 | -0.1% | 13,000 |
| 2025/12/24 | 3,430 | 3,475 | 3,415 | 3,435 | +10 | +0.3% | 26,600 |
| 2025/12/23 | 3,355 | 3,440 | 3,350 | 3,425 | +65 | +1.9% | 32,200 |
| 2025/12/22 | 3,420 | 3,440 | 3,330 | 3,360 | -60 | -1.8% | 40,200 |
| 2025/12/19 | 3,455 | 3,490 | 3,415 | 3,420 | -65 | -1.9% | 45,800 |
| 2025/12/18 | 3,430 | 3,500 | 3,430 | 3,485 | +80 | +2.3% | 25,000 |
| 2025/12/17 | 3,480 | 3,490 | 3,400 | 3,405 | -40 | -1.2% | 34,500 |
| 2025/12/16 | 3,415 | 3,455 | 3,395 | 3,445 | +45 | +1.3% | 33,100 |
| 2025/12/15 | 3,375 | 3,430 | 3,375 | 3,400 | -10 | -0.3% | 13,700 |
| 2025/12/12 | 3,440 | 3,465 | 3,370 | 3,410 | +10 | +0.3% | 33,000 |
| 2025/12/11 | 3,425 | 3,450 | 3,400 | 3,400 | -45 | -1.3% | 16,300 |
| 2025/12/10 | 3,395 | 3,460 | 3,385 | 3,445 | +65 | +1.9% | 19,100 |
| 2025/12/09 | 3,320 | 3,390 | 3,320 | 3,380 | +60 | +1.8% | 18,100 |
| 2025/12/08 | 3,340 | 3,355 | 3,315 | 3,320 | +15 | +0.5% | 22,400 |
| 2025/12/05 | 3,300 | 3,340 | 3,295 | 3,305 | -15 | -0.5% | 20,600 |
| 2025/12/04 | 3,325 | 3,345 | 3,300 | 3,320 | -5 | -0.2% | 33,000 |
| 2025/12/03 | 3,355 | 3,375 | 3,325 | 3,325 | -60 | -1.8% | 47,300 |
| 2025/12/02 | 3,405 | 3,420 | 3,360 | 3,385 | -45 | -1.3% | 32,600 |
| 2025/12/01 | 3,490 | 3,490 | 3,395 | 3,430 | -65 | -1.9% | 34,100 |
| 2025/11/28 | 3,420 | 3,500 | 3,420 | 3,495 | +100 | +2.9% | 37,200 |
| 2025/11/27 | 3,425 | 3,430 | 3,385 | 3,395 | -70 | -2% | 20,800 |
151～
200
件表示中 / 4031件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 328,000円 | +7.7% | +11.7% | 2.59% | 11.54倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 科研薬 | 396,500円 | +17.0% | - | 4.79% | 23.10倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ペプチド | 105,650円 | +72.8% | - | 0.00% | 45.29倍 | 2.80倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ネクセラファーマ | 126,700円 | +39.5% | - | 0.00% | 21.05倍 | 1.79倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業２本柱 |
| ゼリア新薬 | 201,300円 | +6.6% | +17.7% | 2.48% | 8.87倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
